
Learn how Indica Labs’ customers employ HALO products and services to advance their digital pathology.
Indica Labs’ Boston HALO® User Group Meeting
Date: 16 May 2024
Time: 1:00 – 5:00
Location: Le Méridien Boston Cambridge
Summary
Indica Labs has announced their Boston HALO® User Group Meeting at Le Méridien Boston Cambridge. Taking place on May 16 from 1 pm – 5 pm. The event will include a lunch for all pre-registered attendees at 12 pm.
Their program this year features a diverse mix of customer speakers, internal presentations, as well as a presentation from Roche Diagnostics on multiplexing in brightfield. Their guest speakers represent leading universities and pharma companies who will showcase their work using the HALO image analysis platform as well as Indica Labs’ Pharma Services offering.
Indica Labs will present on the new features available in the latest release of HALO, HALO AI, and HALO Link 4.0 and will provide an introduction to their Cloud Services offering.
The Indica team welcomes anyone who is interested in learning more about Indica Labs’ AI-powered digital pathology solutions to register for the meeting. You do not need to be a current Indica Labs customer to attend.
Follow us
Get Pathology News Delivered to Your Inbox
Learn More
More Stories
Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇ
Editor2026-08-14T06:48:56+00:00August 13, 2026|
Pathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided Biopsy
Editor2026-08-13T08:46:16+00:00August 13, 2026|
OnePath Diagnostic Now Runs on elea’s AI-Native Pathology Operating System
Editor2026-08-14T06:49:00+00:00August 13, 2026|
A multisite survey on patient perspectives of breast cancer risk assessment and supplemental breast cancer screening tools
Editor2026-08-12T08:47:23+00:00August 12, 2026|
Keeping Digital Pathology Open: The Regulatory Framework Behind Concentriq AP-Dx
Editor2026-08-10T07:51:40+00:00August 12, 2026|
Lumea Climbs the 2026 Inc. 5000 Ranking, Reflecting Continued Rapid Growth
Editor2026-08-11T14:54:03+00:00August 11, 2026|
Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software
Editor2026-08-11T13:08:19+00:00August 11, 2026|







